GPLD1 and neoplasm: Tumor growth curve analysis (Figure 9a) revealed that while P-PLD, T2-PLD, and D32-PLD were virtually identical with respect to an effect on tumor growth rate and resulted in medium survival times (MST) of 37, 36, and 39 days, respectively, T1-PLD, R3-PLD, and D31-PLD were more effective in slowing or halting B16 melanoma growth.